ConvaTec Group plc
Company characteristics
| Assessed report publication year | |
|---|---|
| Financial year end | 31/12/23 |
| Sector | Health Care |
| Head office | United Kingdom |
| Primary listing | London Stock Exchange |
| GBP market cap | 5,005,586,103 |
| Net profit margin | 6.08% |
| CEO tenure | 4.3 years |
| Employee count | 10,136 |
| FRF draft assessment response |  |
Reward scrutiny
| Living wage accredited | |
Living wage (calculation for operating regions) | |
|---|---|---|---|
| Living hours accredited |  |
Tax reporting (GRI 207) | |
Remuneration policies
| Remuneration committee 100% independent | |
Remuneration committee discretion applied | |
|---|---|---|---|
| Director from workforce | |
Trade union relations (disclosure) | |
| Worker consultation on top pay (disclosure) | |
80%+ shareholder support on pay | |
Reward outcomes
| CEO total pay (GBP) | 4,264,000 | CEO total pay change | -1.77% |
|---|---|---|---|
| CEO pay ratio (to median employee) | 80:1 | Percentage point increase in maximum variable remuneration | — |
| Pension award parity between CEO and wider workforce | |
Pay of the next highest exec compared to CEO | 37.19% |
| Gender pay gap (mean data) | 12.11%: overall 4.94%: Convatec ltd | Gender pay (women % in top quartile) | 44.00% |
| Ethnicity pay gap (disclosure) | |
Total dividend (USD) | 127,701,890 |